<DOC>
	<DOC>NCT00286260</DOC>
	<brief_summary>Polyneuropathy of different etiologies is often associated with pain. The standard treatment of this pain is anticonvulsants or antidepressants, but none of these treatment are effective or tolerable for all patients. Levetiracetam is a newer anticonvulsant and it is the hypothesis is that it could relieve neuropathic pain in polyneuropathy. This is a randomised, double-blind, placebo-controlled, cross-over trial on the effect of levetiracetam 3.000 mg/day on pain in polyneuropathy</brief_summary>
	<brief_title>Levetiracetam for Painful Polyneuropathy</brief_title>
	<detailed_description />
	<mesh_term>Pain</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>age 20 to 0 years painful symptoms of polyneuropathy for at least 6 months confirmed diagnosis of polyneuropathy baseline pain score of 4 or more (0 to 10 point scale) pain at least 4 days a week adequate anticonceptive treatment for women with childbearing potential informed consent other cause of pain previous allergic reactions towards levetiracetam known adverse drug reactions on levetiracetam pregnancy severe disease inability to follow study protocol treatment with antidepressants, other anticonvulsants or opioids</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>polyneuropathy</keyword>
	<keyword>neuropathic pain</keyword>
	<keyword>levetiracetam</keyword>
</DOC>